Ticker LaunchIPO · BEAT
HeartBeam, Inc.
HeartBeam, Inc. (BEAT) priced its initial public offering on Nov 12, 2021 at $5.34 per share, raising $16.5M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $41.7M. Lucosky Brookman advised the company and Schiff Hardin advised the underwriters.
HeartBeam, Inc. is a medical technology company developing telemedicine solutions to detect and monitor cardiac disease outside healthcare facilities. Its remote diagnostic products target ambulatory and emergency room use and require FDA clearance, which they have not yet received.
- Status
- IPO
- Ticker
- BEAT
- Exchange
- Nasdaq Capital Market
- Priced
- Nov 12, 2021
- IPO price
- $5.34
- Raised
- $16.5M
- Market cap at IPO price
- $41.7M
- First filed
- Sep 7, 2021
- Company counsel
- Lucosky Brookman
- Underwriters' counsel
- Schiff Hardin
- Sector
- Healthcare
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 7, 2021
- Latest amendment Nov 9, 2021
- Final prospectus (424B4) Nov 12, 2021
- All filings on EDGAR CIK 1779372
Other Healthcare IPOs in 2021
- Bluejay Diagnostics, Inc.BJDX · Nov 12, 2021 · $21.6M
- Cadre Holdings, Inc.CDRE · Nov 5, 2021
- MDxHealth SAMDXH · Nov 5, 2021 · $45M
- Sonendo, Inc.SONX · Nov 1, 2021 · $93.6M
- Airsculpt Technologies, Inc.AIRS · Oct 29, 2021 · $77M
- Marpai, Inc.MRAI · Oct 28, 2021